Something like that. I was thinking, based on the discussion here, of taking one bottle of Swanson Fistein (30 x 100 mg), dividing it in two, then take that 1500 mg spaced over three doses for two days. That's based on 22 mg/kg for myself @ 68kgs.
Anyone have any add'l components that might be useful at the same time?
To expand on my own question and suggested dosing, based on the article below, perhaps a 5 day regimen would be better (safer, more effective) than a higher dose 2 day one, and also combined with quercetin and piperlongumine, both of which are readily available. I'm still gauging what I will eventually try, but this is all good information.
"Given that, results from the recent animal study of fisetin noted here greatly exceed expectations, surprisingly so. Fisetin appears about as effective in mice as any of the current top senolytics, such as the chemotherapeutics dasatinib and navitoclax. Per the data in the open access paper below, dosing with fisetin destroys 25-50% of senescent cells depending on organ and method of measurement. The dose level is large in absolute terms, as one might expect for a flavonoid. For aged mice and a one-time treatment, the researchers used 100 mg/kg daily for five days. The usual approach to scale up estimated doses from mouse studies to initial human trials leads to 500 mg per day for five days for a 60 kg human.
Given the wealth of new results emerging these days, it seems to me that people focused on self-experimentation, open human trials, and investigative mouse studies in this field should be moving to focus on combination therapies. Consider a combination of fisetin, dasatinib, quercetin, piperlongumine, and FOXO4-DRI- multiple different mechanisms to provoke apoptosis that are all hitting senescent cells at the same time. The goal would be to see if it is possible to engineer a significantly higher level of clearance of senescent cells than any of these senolytics can achieve on their own. This seems like a plausible goal, and may turn out to present meaningful competition to efforts such as those of Oisin Biotechnologies and other groups developing more sophisticated senolytic therapies that should have high rates of clearance."
https://www.fightagi...tive-senolytic/